Cantor Fitzgerald’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$774K Buy
+2,924
New +$771K 0.01% 388
2025
Q3
– Sell
-2,091
Closed -$319K – 464
2025
Q2
$319K Buy
2,091
+100
+5% +$15.4K 0.01% 263
2025
Q1
$330K Buy
+1,991
New +$312K 0.01% 178
2024
Q3
– Sell
-26,501
Closed -$3.87M – 256
2024
Q2
$3.87M Buy
26,501
+12,903
+95% +$1.92M 0.76% 31
2024
Q1
$2.15M Sell
13,598
-874
-6% -$139K 0.51% 32
2023
Q4
$2.27M Sell
14,472
-234,352
-94% -$35.9M 0.47% 38
2023
Q3
$38.8M Sell
248,824
-3,263
-1% -$538K 1.04% 17
2023
Q2
$41.7M Buy
252,087
+82,966
+49% +$13.4M 0.95% 16
2023
Q1
$26.2M Buy
169,121
+27,547
+19% +$4.45M 0.56% 39
2022
Q4
$25M Buy
141,574
+821
+0.6% +$142K 0.54% 42
2022
Q3
$23M Sell
140,753
-59,854
-30% -$10.1M 0.5% 43
2022
Q2
$35.9M Buy
+200,607
New +$35.7M 0.7% 26

Other funds holding JNJ

Cantor Fitzgerald's JNJ Position: Q3 2026 in Review

Cantor Fitzgerald opened a new position in Johnson & Johnson (JNJ) in Q3 2026: 2,924 shares worth $774K. The stake represents 0.01% of the portfolio and ranks #388 among its holdings. This is a return to the name: Cantor Fitzgerald previously reported a position in JNJ as recently as Q2 2025.

Cantor Fitzgerald first reported a position in JNJ in Q2 2022 and has held it in 12 quarters since. The position peaked at $41.7M in Q2 2023. 4,739 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • Cantor Fitzgerald held 2,924 shares of Johnson & Johnson worth $774K as of Q3 2026.
  • Johnson & Johnson was a new Cantor Fitzgerald position in Q3 2026.
  • Johnson & Johnson made up 0.01% of Cantor Fitzgerald's portfolio in Q3 2026, its #388 holding.
  • Cantor Fitzgerald first reported a position in Johnson & Johnson in Q2 2022 and has held it in 12 quarters since.
  • Cantor Fitzgerald's Johnson & Johnson position peaked at $41.7M in Q2 2023.
  • 4,739 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on Cantor Fitzgerald's 13F filing for Q3 2026, filed 16 Nov 2026.